Medicare does cover Breo Ellipta. The inhaler falls under Medicare Part D, so any standalone Part D plan or Medicare Advantage plan with prescription drug coverage should include it, most often on Tier 3 as a preferred brand. What you pay depends on your plan’s copay or coinsurance, but two things are changing the math in beneficiaries’ favor: a $2,000 annual out-of-pocket cap on Part D drugs, and a negotiated maximum price of $67 for a 30-day supply that takes effect January 1, 2027, an 83% cut from the 2024 list price of $397.1CMS. Fact Sheet: Negotiated Prices for Initial Price Applicability Year 2027
Why Breo Ellipta Falls Under Part D, Not Part B
Medicare splits inhaled medications by how they’re delivered. Drugs given through a home nebulizer are covered under Part B as durable medical equipment. Handheld inhalers, including dry powder inhalers like Breo Ellipta, metered-dose inhalers, and nasal sprays, are covered under Part D.2Medicare Rights Center. Part B vs. Part D Drugs3MVP Health Care. Medicare Part B vs. Part D Determination If you have Original Medicare alone, without a Part D plan, Breo Ellipta is not covered. You need Part D coverage, either standalone or bundled into a Medicare Advantage plan.
What You Pay Now
Breo Ellipta shows up consistently on Tier 3 (preferred brand) across 2026 standalone Part D formularies.4Q1Medicare. Medicare Part D Drug Finder, Breo Ellipta5Humana. Breo Ellipta Coverage6Humana. Commonly Prescribed Medication List
Cost sharing at that tier runs from flat copays of about $45 to coinsurance in the range of 17% to 25% of the plan’s negotiated retail price.4Q1Medicare. Medicare Part D Drug Finder, Breo Ellipta With 2026 retail prices reported between roughly $373 and $424 for a 30-day supply, a 25% coinsurance rate works out to about $93 to $106 a month before other cost protections kick in.7Q1Medicare. Breo Ellipta Retail Drug Price, Humana Premier Rx
Quantity Limits, Prior Authorization, and Exceptions
Most plans set a quantity limit of 60 units per 30 days, which equals one inhaler (30 blisters, counted as two units each in billing systems).4Q1Medicare. Medicare Part D Drug Finder, Breo Ellipta Some plans layer on prior authorization or step therapy, meaning you may need to try a cheaper alternative first. Whether those apply depends on the specific plan. If a restriction would be medically inappropriate, you or your prescriber can request an exception, and plans generally must respond within 72 hours of receiving your prescriber’s supporting statement.8Blue MedicareRx. Value Plus Formulary
The $2,000 Cap and Monthly Payment Option
Whatever your plan charges per fill, your total out-of-pocket spending on Part D drugs is now capped. Under the Inflation Reduction Act, the annual maximum is $2,000 in 2025 and $2,100 in 2026, indexed to Part D cost growth going forward.9KFF. Changes to Medicare Part D Under the Inflation Reduction Act10NCOA. What You Will Pay in Out-of-Pocket Medicare Costs in 2026 Once you hit the cap, covered prescriptions cost $0 for the rest of the year. If you’re paying $100 or so a month for Breo Ellipta plus other Part D drugs, you’ll typically reach the cap partway through the year and pay nothing for refills after that.
You can also spread those out-of-pocket costs across the year through the Medicare Prescription Payment Plan. Enrollment is voluntary and open to anyone with Part D. Participants pay nothing at the pharmacy counter and instead receive a monthly bill from their plan, calculated by dividing remaining costs by the months left in the year.11Medicare.gov. Medicare Prescription Payment Plan Examples There are no interest charges or late fees, though falling more than two months behind can get you removed from the program.12PAN Foundation. Understanding the Medicare Prescription Payment Plan It doesn’t reduce your total cost. It just smooths the timing. Participation renews each year automatically unless you opt out or change plans.13Medicare.gov. What’s the Medicare Prescription Payment Plan
The 2027 Price Cut to $67
Breo Ellipta was selected for the second round of Medicare drug price negotiations under the Inflation Reduction Act. CMS announced the result in 2025: a maximum fair price of $67 for a 30-day supply, an 83% reduction from the 2024 wholesale acquisition cost of $397.1CMS. Fact Sheet: Negotiated Prices for Initial Price Applicability Year 202714CMS. Selected Drugs and Negotiated Prices The new price takes effect January 1, 2027, across all Medicare Part D plans, including Medicare Advantage drug plans.15ACAAI. 2027 Medicare Price Reductions for Asthma Inhalers About 626,000 Medicare enrollees used Breo Ellipta in 2024.16BioPharma Dive. Medicare Price Negotiation: Wegovy, Ozempic, Trelegy 2027
The $67 figure becomes the new baseline for calculating copays and coinsurance. A beneficiary paying 25% coinsurance would owe less than $17 per fill instead of $100 or more.
Lowering Your Costs Before 2027
Extra Help
If your income and resources are limited, Extra Help (also called the Low Income Subsidy) eliminates Part D premiums and deductibles and caps copays at low fixed amounts. In 2026, Extra Help limits copays for brand-name drugs like Breo Ellipta to no more than $12.65. Those who also have full Medicaid pay no more than $4.90 per prescription.17Medicare.gov. Get Help With Drug Costs18NCOA. Understanding Medicare Part D Low Income Subsidy (Extra Help) For 2026, individuals not enrolled automatically must have income up to $23,940 and resources up to $18,090, with higher limits for married couples. If you have Medicaid, Supplemental Security Income, or a Medicare Savings Program, you’re enrolled automatically.
GSK Patient Assistance
GSK, the manufacturer, runs a Patient Assistance Program through the GSK Patient Assistance Programs Foundation that can provide Breo Ellipta at no cost to eligible patients, including Medicare beneficiaries who meet income requirements.19GSK PAF. GSK Prescription Medicine Patient Assistance20GSKForYou. Terms and Conditions21GSKForYou. GSK Coupons and Free Trials
Compare Plans During Open Enrollment
Tier placement and cost sharing for Breo Ellipta vary meaningfully from plan to plan. During the annual Medicare Open Enrollment Period, October 15 through December 7, you can use the Medicare Plan Finder at medicare.gov to see which plan gives you the lowest cost for your specific medications.22Allergy and Asthma Network. Medicare Part D Drug Coverage Some formularies place therapeutic alternatives like Wixela Inhub (a generic version of Advair Diskus) on a lower, cheaper tier.6Humana. Commonly Prescribed Medication List Switching medications is a clinical decision you’d make with your prescriber, but knowing what a plan prefers is useful information for that conversation.
A Generic Isn’t Really an Option Yet
A fully approved generic version of fluticasone furoate/vilanterol is not widely available. Transpire Bio has had an abbreviated new drug application accepted for filing by the FDA, but full approval had not been granted as of the most recent available information.23FirstWord Pharma. Transpire Bio ANDA for Generic Breo Ellipta Humana currently covers the brand-name Breo Ellipta but not the authorized generic, noting that the generic’s cost share could be equal to or higher than the brand’s.5Humana. Breo Ellipta Coverage That could shift as generic competition develops, but for now most Medicare beneficiaries filling a Breo Ellipta prescription will get the brand-name inhaler.